U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07670143) titled 'M1no-Study - Early Identification of Infants With High Type 1 Diabetes Risk for Participation in Primary Prevention Trials' on June 18.
Brief Summary: The goal of this observational study is to identify newborns at increased genetic risk of developing type 1 diabetes-specific beta-cell autoantibodies in order to determine eligibility for participation in primary prevention randomized controlled trials aimed at preventing beta-cell autoimmunity.
Study Start Date: July, 2026
Study Type: OBSERVATIONAL
Condition:
Type 1 Diabetes
Recruitment Status: NOT_YET_RECRUITING
Sponsor: IRCCS San Raffaele
Information provided by (Responsibl...